Table 1.
RIFLE | AKIN | KDIGO | ||||||
---|---|---|---|---|---|---|---|---|
Class | Creatinine Criteria | Urine Output Criteria | Stage | Creatinine Criteria | Urine Output Criteria | Stage | Creatinine Criteria | Urine Output Criteria |
Risk | SCr ≥ 1.5 times baseline OR GFR decline ≥ 25% | <0.5 mL/kg/h for ≥6 h | Stage 1 | SCr ≥ 1.5 times baseline or increase by 0.3 mg/dL within 48 hours | <0.5 mL/kg/h for ≥6 h | Stage 1 | SCr increase by 0.3 mg/dL within 48 hours OR SCr ≥ 1.5–1.9 times baseline within 7 days | <0.5 mL/kg/h for ≥6 h |
Injury | SCr ≥ 2 times baseline OR GFR decline ≥ 50% | <0.5 mL/kg/h for ≥12 h | Stage 2 | SCr ≥ 2 times baseline | <0.5 mL/kg/h for ≥12 h | Stage 2 | SCr ≥ 2.0–2.9 times baseline within 7 days | <0.5 mL/kg/h for ≥12 h |
Failure | SCr ≥ 3 times baseline or increase by 0.5 mg/dL to ≥ 4 mg/dL OR GFR decline ≥ 75% OR RRT Initiation | <0.3 mL/kg/h for 24 h OR Anuria for 12 h | Stage 3 | SCr ≥ 3 times baseline or increase by 0.5 mg/dL to ≥ 4 mg/dL OR RRT Initiation | <0.3 mL/kg/h for 24 h OR Anuria for 12 h | Stage 3 | SCr ≥ 3 times baseline or increase by 0.5 mg/dL to ≥ 4 mg/dL OR RRT Initiation | <0.3 mL/kg/h for 24 h OR Anuria for 12 h |
Loss | Loss of renal function for ≥ 4 weeks | |||||||
End-Stage | Loss of renal function for ≥ 3 months |